Reduced copy numbers of IGSF9 and PRDM16 and the increased copy number of ALDH2 were intricately intertwined with lymph node metastasis and reduced survival rates in IMPC patients. Here, IGSF9 is linked to metastatic malignant neoplasm in the lymph nodes.